Article
Neurofibromatosis type 2 attributable to gonosomal mosaicism in a clinically normal mother, and identification of seven novel mutations in the NF2 gene.
Human genetics - 1 Oct 2000
Sestini R, Vivarelli R, Balestri P, Ammannati F, Montali E, Papi L
Abstract excerpt
Neurofibromatosis type 2 (NF2) is an autosomal dominant cancer syndrome that predisposes to the development of bilateral vestibular schwannomas sometimes associated with schwannomas at other locations, meningiomas, ependymomas and juvenile posterior subcapsular lenticular opacities. This disease is caused by inactivating mutations in the NF2 tumour-suppressor gene, located in 22q12. Recently, somatic mosaicism...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
